Nesina and Avapro drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Nesina (alogliptin benzoate) and Avapro (irbesartan). Common drug interactions include pemphigoid among females and interstitial lung disease among males.

The phase IV clinical study analyzes what interactions people have when they take Nesina and Avapro. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Nesina?

Nesina has active ingredients of alogliptin benzoate. eHealthMe is studying from 2,297 Nesina users. Check the latest studies of Nesina.

What is Avapro?

Avapro has active ingredients of irbesartan. It is often used in high blood pressure. eHealthMe is studying from 19,840 Avapro users. Check the latest studies of Avapro.

On Jul, 29, 2026

14 people who take Nesina and Avapro together, and have interactions are studied.

What are the common drug interactions of Nesina and Avapro, by gender? *:

female:

Pemphigoid (tense blisters on the skin)
Glycosylated haemoglobin increased
Urine ketone body present
Acquired haemophilia (bleeding disorder disease)
Cardiac failure acute
Cerebral infarction (less blood supply to brain resulting tissue damage)
Hyperglycaemia (high blood sugar)
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)

male:

Interstitial lung disease
Pancreatitis acute (sudden inflammation of pancreas)
Oesophageal varices haemorrhage (bleeding from extremely dilated sub-mucosal veins in the lower third of the oesophagus)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Cardiac failure
Colitis ischaemic (due to infection of intestine impaired blood supply to colon)
Decreased appetite
Disease complication
Gastrointestinal disorder (functional problems of gastrointestinal tract)
Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)

What are the common drug interactions of Nesina and Avapro, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Interstitial lung disease

60+:

Pemphigoid (tense blisters on the skin)
Glycosylated haemoglobin increased
Colitis ischaemic (due to infection of intestine impaired blood supply to colon)
Decreased appetite
Disease complication
Gastrointestinal disorder (functional problems of gastrointestinal tract)
Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
Hyperglycaemia (high blood sugar)
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Nephrotic syndrome (kidney disease with proteinuria, hypoalbuminemia, and oedema)

What are the existing conditions these people have? *

Type 2 Diabetes: 9 people, 64.29%
Diabetes: 4 people, 28.57%
Dyslipidaemia (abnormal amount of lipids): 2 people, 14.29%
Diabetic Neuropathy (neuropathic disorders that are associated with diabetes mellitus): 2 people, 14.29%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 7.14%
Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 7.14%
Haemostasis (stopping of bleeding): 1 person, 7.14%
Gastritis - Chronic (long lasting inflammation of stomach): 1 person, 7.14%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 1 person, 7.14%
Diabetic Nephropathy (diabetic kidney disease): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Nesina and Avapro?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously